BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16773520)

  • 1. [Infliximab in active ulcerative colitis -- proven efficacy as induction and maintenance treatment].
    Heidemann J; Kucharzik TF
    Z Gastroenterol; 2006 Jun; 44(6):540-2. PubMed ID: 16773520
    [No Abstract]   [Full Text] [Related]  

  • 2. [News from the Cochrane Library: Maintenance of remission in ulcerative colitis].
    Timmer A
    Z Gastroenterol; 2007 May; 45(5):395-6. PubMed ID: 17503319
    [No Abstract]   [Full Text] [Related]  

  • 3. A review of infliximab use in ulcerative colitis.
    Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
    Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
    Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of infliximab in ulcerative colitis].
    Tilg H; Feichtenschlager T; Knoflach P; Petritsch W; Schöfl R; Vogelsang H; Reinisch W
    Z Gastroenterol; 2007 Aug; 45(8):907-11. PubMed ID: 17701864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [TNF-alpha antibody treatment and remission induction in ulcerative colitis: a review of a Cochrane review].
    Bjerrum JT; Munck LC; Krogh-Madsen M; Nielsen OH
    Ugeskr Laeger; 2007 Feb; 169(9):792-5. PubMed ID: 17355842
    [No Abstract]   [Full Text] [Related]  

  • 7. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
    Ainsworth MA; Brynskov J
    Ugeskr Laeger; 2007 Feb; 169(9):789-91. PubMed ID: 17355841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab for the treatment of ulcerative colitis.
    Eshuis EJ; Bemelman WA; Stokkers PC
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):219-29. PubMed ID: 19485804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab: new indication. Ulcerative colitis: caution is needed due to long-term risks.
    Prescrire Int; 2007 Oct; 16(91):194. PubMed ID: 17926832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis.
    Tsai HH; Punekar YS; Morris J; Fortun P
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1230-9. PubMed ID: 18729845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of anti-TNF therapy in ulcerative colitis].
    Cuković-Cavka S; Vucelić B; Urek MC; Brinar M; Turk N
    Acta Med Croatica; 2013 Apr; 67(2):171-7. PubMed ID: 24471300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annular purpura and ulcerative colitis: response to infliximab.
    Tan V; Bartlett M; Hosking P; Gibson PR
    Dig Liver Dis; 2007 May; 39(5):488-9. PubMed ID: 17383245
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biological drugs in inflammatory bowel disease. Valuable supplement--but only when conventional therapy is not sufficient].
    Hellström PM; Schmidt D; Karlén P
    Lakartidningen; 2007 Oct 10-16; 104(41):2973-6. PubMed ID: 17977308
    [No Abstract]   [Full Text] [Related]  

  • 16. Is keeping the colon the ultimate marker of success in ulcerative colitis?
    Nguyen GC; Prather CM
    Gastroenterology; 2009 Oct; 137(4):1204-6. PubMed ID: 19717125
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab in ulcerative colitis.
    Aberra FN; Lichtenstein GR
    Gastroenterol Clin North Am; 2006 Dec; 35(4):821-36. PubMed ID: 17129815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical treatment and management of severe ulcerative colitis.
    Rizzello F; Campieri M; Tambasco R; Straforini G; Brugnera R; Poggioli G; Gionchetti P
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S280-4. PubMed ID: 18599001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: the management of steroid dependency in ulcerative colitis.
    Bianchi Porro G; Cassinotti A; Ferrara E; Maconi G; Ardizzone S
    Aliment Pharmacol Ther; 2007 Sep; 26(6):779-94. PubMed ID: 17767462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids.
    Rahimi R; Nikfar S; Abdollahi M
    Med Sci Monit; 2007 Jul; 13(7):PI13-8. PubMed ID: 17599035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.